Lots of interesting abstracts and cases were submitted for TCTAP & AP VALVES 2020 Virtual. Below are accepted ones after thoroughly reviewed by our official reviewers. Don’t miss the opportunity to explore your knowledge and interact with authors as well as virtual participants by sharing your opinion!
* The E-Science Station is well-optimized for PC.
We highly recommend you use a desktop computer or laptop to browse E-posters.
ABS20191115_0008
| Acute Coronary Syndromes (STEMI, NSTE-ACS) | |
| Intracoronary Fibrinolytic Therapy in ACS Study of Direct Intralesional Eptifibatide and Alteplase in Primary PCI for the Management of Acute STEMI Patients Within 12 Hours of Symptom Onset | |
| Zulfikri Mukhtar1, Sutomo Kasiman2, Nizam Zikri Akbar3, Henry Panjaitan4, Harris Hasan5 | |
| Adam Malik General Hospital, Indonesia1, Columbia Asia Medan, Indonesia2, Murni Teguh Memorial Hospital, Indonesia3, Grandmed Hospital, Indonesia4, University of Sumatera Utara, Indonesia5 | |
|
Background:
This study aims to evaluate the potentiation effects of local intracoronary or intralesional single bolus administration of eptifibatide (EPT) and alteplase (ALP) to lysis the occlusive thrombus and distal micro-embolization in acute STEMI patients with TIMI 0/1.
|
|
|
Methods:
This is a prospective nonrandomized controlled study. We included acute STEMI patients TIMI flow 0-1 and symptom onset 2-12 h. The culprit vessel was recanalized by TBE or balloon inflation, continued administration of EPT 3.75 mg, ALP 3 mg in 10 mL saline. After stent deployment NTG 200 µg was added. The control group is colleagues’ patients who performed pPCI without ALP. TIMI, MBG, and cTFC were graded by two interpreters.
|
|
|
Results:
There were 220 patients from October 2016 to July 2019, age 26-81 year, 201 males, 19 females, 119 anterior and 101 inferior wall infarctions. Preprocedural TIMI and MBG 0 were 182 patients, TIMI and MBG 1 were 38 patients. Postprocedural TIMI and MBG 3 were 197 patients, TIMI and MBG 2 were 23 patients, DTWCT 2 - 250 minutes (DTWCT <90 were 67 patients, DTWCT 91 to 120were 49 patients and DTWCT >121 minutes were104 patients), median-cTFC 16.3, LVEF increased7.44 - 31.5 %. There were 2 patients with gums bleeding, 1 hematuria, hospital mortality was 2.80 %, no mortality was found during 30 days follow-up. The control group was 210 patients. Postprocedural TIMI and MBG 3 were 123 patients, TIMI and MBG 2 were 83patients, TIMI and MBG 1 were 4 patients. median-cTFC 20.0. Statistically, there was significant difference in postprocedural TIMI, MBG flow, cTFC between the 2 groups (p=0.001).
|
|
|
Conclusion:
Local intracoronary or intralesional eptifibatide, alteplase, and nitroglycerine showed a better result in reperfusion of myocardial blood flow and improved LV function.
|
|
0